project id: TCGA-UCEC; case submitter id: TCGA-AX-A06J; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.6; spectrophotometer method: UV Spec; age at index: 71; days to birth: -26000; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 26000; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 913.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 662; initial weight: 200.0; oct embedded: false; preservation method: Unknown; sample id: fa750459-78d8-4dd7-890b-45729bad112a; sample submitter id: TCGA-AX-A06J-01A; portion id: 7ab839b8-df38-4cf5-b67d-7f32ccec757a; portion submitter id: TCGA-AX-A06J-01A-11; percent lymphocyte infiltration: 0.0; percent normal cells: 3.0; percent tumor nuclei: 95.0;